These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2003 related articles for article (PubMed ID: 17264945)

  • 41. Prolonged travel and venous thromboembolism findings from the RIETE registry.
    Tsoran I; Saharov G; Brenner B; Barrón M; Valdés V; de la Roca Toda M; Monreal M
    Thromb Res; 2010 Oct; 126(4):287-91. PubMed ID: 20624636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey.
    Voke J; Keidan J; Pavord S; Spencer NH; Hunt BJ;
    Br J Haematol; 2007 Nov; 139(4):545-58. PubMed ID: 17916101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry.
    Nuñez MJ; Villalba JC; Cebrián E; Visoná A; Lopez-Jimenez L; Núñez M; Szwebel TA; Luque JM; Jaras MJ; Monreal M;
    Thromb Res; 2012 Aug; 130(2):173-7. PubMed ID: 22374336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of venous thromboembolism in pregnancy.
    Greer IA
    Eur J Med Res; 2004 Mar; 9(3):135-45. PubMed ID: 15096324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.
    Al Sayegh F; Almahmeed W; Al Humood S; Marashi M; Bahr A; Al Mahdi H; Bakir S; Al Farhan M
    Clin Appl Thromb Hemost; 2009; 15(3):289-96. PubMed ID: 18400764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
    Prandoni P; Carnovali M; Marchiori A;
    Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium.
    Nelson SM; Greer IA
    Obstet Gynecol Clin North Am; 2006 Sep; 33(3):413-27. PubMed ID: 16962918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry.
    Arcelus JI; Monreal M; Caprini JA; Guisado JG; Soto MJ; Núñez MJ; Alvárez JC;
    Thromb Haemost; 2008 Mar; 99(3):546-51. PubMed ID: 18327403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry.
    Blanco-Molina A; Trujillo-Santos J; Tirado R; Cañas I; Riera A; Valdés M; Monreal M;
    Thromb Haemost; 2009 Mar; 101(3):478-82. PubMed ID: 19277408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Venous thromboembolism in nonagenarians. Findings from the RIETE Registry.
    Vasco B; Villalba JC; Lopez-Jimenez L; Falga C; Montes J; Trujillo-Santos J; Monreal M;
    Thromb Haemost; 2009 Jun; 101(6):1112-8. PubMed ID: 19492156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A review of medical records and discharge summary data found moderate to high predictive values of discharge diagnoses of venous thromboembolism during pregnancy and postpartum.
    Larsen TB; Johnsen SP; Møller CI; Larsen H; Sørensen HT
    J Clin Epidemiol; 2005 Mar; 58(3):316-9. PubMed ID: 15718123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of dalteparin (Fragmin) on thrombin generation in pregnant women with venous thromboembolism: significance of the factor V Leiden mutation.
    Schambeck CM; Eberl E; Geisen U; Grossmann R; Keller F
    Thromb Haemost; 2001 May; 85(5):782-6. PubMed ID: 11372668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review.
    Duhl AJ
    J Reprod Med; 2008 Sep; 53(9):657-66. PubMed ID: 18839817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Venous thromboembolism. A review.
    Thorneycroft IH; Goldzieher JW
    J Reprod Med; 2003 Nov; 48(11 Suppl):911-20. PubMed ID: 14686028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry.
    Ruíz-Giménez N; Suárez C; González R; Nieto JA; Todolí JA; Samperiz AL; Monreal M;
    Thromb Haemost; 2008 Jul; 100(1):26-31. PubMed ID: 18612534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.
    Johnston JA; Brill-Edwards P; Ginsberg JS; Pauker SG; Eckman MH
    Am J Med; 2005 May; 118(5):503-14. PubMed ID: 15866253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Thromboprophylaxis during pregnancy and the puerperium: highlights from current guidelines].
    Rath W
    Z Geburtshilfe Neonatol; 2010 Dec; 214(6):217-28. PubMed ID: 21207321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 101.